ISPUP

Sobre
Publicações

Clara Castro obtained her degree in Mathematics from the Faculty of Sciences, University of Porto (FCUP) in 2008; MSc in Quantitative Methods in Economics and Management from the Faculty of Economics, University of Porto (FEP) in 2010 and PhD in Public Health from the Faculty of Medicine, University of Porto (FMUP) in 2016.

She works as a Biostatistician at the Department of Epidemiology of the Portuguese Oncology Institute of Porto (IPO-Porto) since 2009, acting as liaison person for several international epidemiology research projects, e.g. EUROCARE (Survival of cancer patients in Europe), RARECARENet (Information Network of Rare Cancers), European High Resolution Studies (Determinants of incidence and survival of patients with breast, colon and lung cancer, skin melanoma and non-Hodgkin lymphoma), and EUROCHIP (Health Indicators for Monitoring Cancer in Europe). She is a member of the GRELL (Group for Cancer Epidemiology and Registration in Latin Language Countries) Steering Committee since 2017.

She is currently a Research member of the Epidemiology Research Group at IPO-Porto Research Centre (CI-IPOP), and of the Non Communicable Diseases Epidemiology Group of the Epidemiology Research Unit (EPIUnit) at Institute of Public Health of the University of Porto. Her major research interests are focused on cancer determinants and disease predictive models.

ORCID: 0000-0001-9653-4581

Ano

Título

Artigos

2020

Forjaz G , Bastos J , Castro C , Mayer A, Noone AM, Chen HS, Mariotto AB

Regional differences in tobacco smoking and lung cancer in Portugal in 2018: a population-based analysis using nationwide incidence and mortality data.

BMJ Open, 2020 Oct 23;10(10):e038937. doi: 10.1136/bmjopen-2020-038937.

2020

Minicozzi P, Vicentini M, Innos K , Castro C , Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sánchez MJ, Bielska-Lasota M, Rossi PG, Sant M; Eur

Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.

Eur J Surg Oncol, 2020 Feb 21. pii: S0748-7983(20)30125-6. doi: 10.1016/j.ejso.2020.02.023. [Epub ahead of print]

2019

Santos AP , Castro C , Antunes L , Henrique R , Cardoso MH , Monteiro MP

Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome.

J Clin Med, 2019 Sep 17;8(9). pii: E1479. doi: 10.3390/jcm8091479.

2019

Morais S , Castro C , Antunes L , Peleteiro B , Bento MJ , Lunet N

Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles.

Eur J Cancer Prev, 2019 May;28(3):159-166. doi: 10.1097/CEJ.0000000000000447.

2019

Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R , Castro C , Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Rossi PG, Larrañaga N , Bastos J , Sánchez MJ, Sant M; European HR Working Group on breast cancer.

Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.

Int J Cancer, 2019 May 1;144(9):2118-2127. doi: 10.1002/ijc.31974. Epub 2018 Dec 27.

2018

Come J , Castro C , Morais A, Cossa M, Modcoicar P , Tulsidas S , Cunha L, Lobo V, Morais AG, Cotton S , Lunet N , Carrilho C , Santos LL

Clinical and Pathologic Profiles of Esophageal Cancer in Mozambique: A Study of Consecutive Patients Admitted to Maputo Central Hospital.

J Glob Oncol, 2018 Nov;(4):1-9. doi: 10.1200/JGO.18.00147.

2018

Santos AP , Santos AC , Castro C , Raposo L , Pereira SS , Torres I , Henrique R , Cardoso H , Monteiro MP

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors.

Cancers (Basel), 2018 Aug 27;10(9). pii: E293. doi: 10.3390/cancers10090293.

2018

Unsal AA, Kılıç S, Dubal PM, Baredes S, Eloy JA; EUROCARE-5 Working Group: , Castro C

A population-based comparison of European and North American sinonasal cancer survival.

Auris Nasus Larynx, 2018 Aug;45(4):815-824. doi: 10.1016/j.anl.2017.09.009. Epub 2017 Oct 19.

2018

Forjaz de Lacerda G, Kelly SP , Bastos J , Castro C , Mayer A, Mariotto AB, Anderson WF

Breast cancer in Portugal: Temporal trends and age-specific incidence by geographic regions.

Cancer Epidemiol, 2018 Jun;54:12-18. doi: 10.1016/j.canep.2018.03.003. Epub 2018 Mar 13.

2018

Castro C , Peleteiro B , Morais S , Severo M , Santos MJ , Lunet N

An explanatory and predictive model of the variation in esophageal cancer incidence on the basis of changes in the exposure to risk factors.

Eur J Cancer Prev, 2018 May;27(3):213-220. doi: 10.1097/CEJ.0000000000000422.

2018

Castro C , Peleteiro B , Lunet N

Modifiable factors and esophageal cancer: a systematic review of published meta-analyses.

J Gastroenterol, 2018 Jan;53(1):37-51. doi: 10.1007/s00535-017-1375-5. Epub 2017 Aug 18.

2017

Castro C , Dinis-Ribeiro M, Rodrigues ANG, Calheiros T, Santos J, Pereira P, Ramos M, Cunha H5, Andrade M, Costa A, Sá L , Antunes L , Bento MJ, Lomba-Viana R

Western long-term accuracy of serum pepsinogen-based gastric cancer screening.

Eur J Gastroenterol Hepatol, 2017 Dec 5. doi: 10.1097/MEG.0000000000001040. [Epub ahead of print]

2017

Pina F , Castro C , Ferro A , Bento MJ , Lunet N

Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.

Eur J Cancer Prev, 2017 Sep;26(5):404-410. doi: 10.1097/CEJ.0000000000000285.

2017

Castro C , Peleteiro B , Bento MJ , Lunet N

Trends in gastric and esophageal cancer incidence in northern Portugal (1994-2009) by subsite and histology, and predictions for 2015.

Tumori, 2017 Mar 24;103(2):155-163. doi: 10.5301/tj.5000542. Epub 2016 Aug 23.

2016

Gacio MF, Lousame AM , Pereira S , Castro C , Santos J